Abbott's board announced a quarterly dividend of 63 cents per share, payable on November 16, 2026, to shareholders recorded by October 15, 2026. This marks Abbott's 411th consecutive quarterly dividend since 1924 and continues its streak of 54 years of annual dividend increases. Abbott is recognized as a Dividend Aristocrat, reflecting its strong commitment to returning value to shareholders. The company remains a global leader in healthcare with a diverse portfolio serving over 160 countries.
Abbott Laboratories trades at USD 101.45 on Pluang as of September 17, 2026, with a dividend yield of 2.46%. The stock has seen a slight 0.89% decline in the last day and is currently experiencing predominantly sell orders at 97%. This dividend announcement adds to Abbott's long-standing reputation, which is reflected in its stable market presence and investor activity on Pluang.
Abbott has agreed to pay $385 million to resolve investigations and lawsuits related to its 2022 recall of powdered infant formula from its Sturgis, Michigan facility. The settlement does not imply any fault or liability, and the US government has cl...
Medtronic and Abbott are both strong dividend-paying medical device companies, but Medtronic currently offers a higher dividend yield of 3.11% and stronger near-term growth prospects, including accelerating revenue and a planned diabetes business sep...
